An Efficacy and Safety Study of Atabecestat in Participants Who Are Asymptomatic at Risk for Developing Alzheimer's Dementia
Clinical trial NCT02569398 · TERMINATED
Trial details
- NCT number
- NCT02569398
- Sponsor
- Janssen Research & Development, LLC
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-29
- Primary completion
- 2018-12-20
- Enrollment
- 557
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.